These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30149993)

  • 1. Competing risks analysis of the effect of local residual tumour on recurrence and cancer-specific death after resection of colorectal cancer: implications for staging.
    Newland RC; Chan C; Chapuis PH; Keshava A; Rickard MJFX; Young CJ; Dent OF
    Pathology; 2018 Oct; 50(6):600-606. PubMed ID: 30149993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nature of local recurrence after colorectal cancer resection.
    Thomson WH; Foy CJ; Longman RJ
    Colorectal Dis; 2008 Jan; 10(1):69-74. PubMed ID: 17509052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of prognostic significance of conventional peritoneal cytology in colorectal and gastric cancers: results of EVOCAPE 2 multicentre prospective study.
    Cotte E; Peyrat P; Piaton E; Chapuis F; Rivoire M; Glehen O; Arvieux C; Mabrut JY; Chipponi J; Gilly FN;
    Eur J Surg Oncol; 2013 Jul; 39(7):707-14. PubMed ID: 23601984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes of locally or radically resected T1 colorectal cancer.
    Nam MJ; Han KS; Kim BC; Hong CW; Sohn DK; Chang HJ; Kim MJ; Kim SY; Baek JY; Park SC; Oh JH
    Colorectal Dis; 2016 Sep; 18(9):852-60. PubMed ID: 26589573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk for Incomplete Resection after Macroscopic Radical Endoscopic Resection of T1 Colorectal Cancer: A Multicenter Cohort Study.
    Backes Y; de Vos Tot Nederveen Cappel WH; van Bergeijk J; Ter Borg F; Schwartz MP; Spanier BWM; Geesing JMJ; Kessels K; Kerkhof M; Groen JN; Wolfhagen FHJ; Seerden TCJ; van Lelyveld N; Offerhaus GJA; Siersema PD; Lacle MM; Moons LMG
    Am J Gastroenterol; 2017 May; 112(5):785-796. PubMed ID: 28323275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of the lymph node ratio in stage IV colorectal cancer patients who have undergone curative resection.
    Ozawa T; Ishihara S; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Hata K; Kawai K; Nozawa H; Kanazawa T; Kazama S; Yamaguchi H; Sunami E; Kitayama J; Watanabe T
    Ann Surg Oncol; 2015 May; 22(5):1513-9. PubMed ID: 25398278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection.
    Abe S; Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Watanabe T
    J Surg Res; 2016 Oct; 205(2):384-392. PubMed ID: 27664887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated tumor-to-liver uptake ratio (TLR) from
    Huang J; Huang L; Zhou J; Duan Y; Zhang Z; Wang X; Huang P; Tan S; Hu P; Wang J; Huang M
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for metachronous adenoma in the residual colon of patients undergoing curative surgery for colorectal cancer.
    Patel A; Williams N; Parsons N; Ali O; Peters F; Ranat R; Shah J; Spector E; Arasaradnam RP
    Int J Colorectal Dis; 2017 Nov; 32(11):1609-1616. PubMed ID: 28828520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraepithelial tumour infiltrating lymphocytes are associated with absence of tumour budding and immature/myxoid desmoplastic reaction, and with better recurrence-free survival in stages I-III colorectal cancer.
    González IA; Bauer PS; Liu J; Chatterjee D
    Histopathology; 2021 Jan; 78(2):252-264. PubMed ID: 32654226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life and risk of colorectal cancer recurrence and All-cause death among advanced stages of colorectal cancer 1-year after diagnosis.
    Wong CK; Law WL; Wan YF; Poon JT; Lam CL
    BMC Cancer; 2014 May; 14():337. PubMed ID: 24886385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical outcomes for colon and rectal cancer over a decade: results from a consecutive monocentric experience in 902 unselected patients.
    Andreoni B; Chiappa A; Bertani E; Bellomi M; Orecchia R; Zampino M; Fazio N; Venturino M; Orsi F; Sonzogni A; Pace U; Monfardini L
    World J Surg Oncol; 2007 Jul; 5():73. PubMed ID: 17610720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour budding predicts increased recurrence after curative resection for T2N0 colorectal cancer.
    Garfinkle R; Lee L; Boutros M; Cardin MJ; Spatz A; Morin N
    Can J Surg; 2019 Oct; 62(5):334-339. PubMed ID: 31550095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of preoperative bowel obstruction in stage III colorectal cancer.
    Katoh H; Yamashita K; Wang G; Sato T; Nakamura T; Watanabe M
    Ann Surg Oncol; 2011 Sep; 18(9):2432-41. PubMed ID: 21369738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of perineural invasion in stages II and III colorectal cancer.
    Zhou Y; Wang H; Gong H; Cao M; Zhang G; Wang Y
    Pathol Res Pract; 2015 Nov; 211(11):839-44. PubMed ID: 26429129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Significance of Preoperative Serum Carbohydrate Antigen 19-9 in Patients With Stage IV Colorectal Cancer.
    Ozawa T; Ishihara S; Kawai K; Nozawa H; Yamaguchi H; Kitayama J; Watanabe T
    Clin Colorectal Cancer; 2016 Dec; 15(4):e157-e163. PubMed ID: 27245559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative complications do not impact on recurrence and survival after curative resection of gastric cancer.
    Climent M; Hidalgo N; Vidal Ó; Puig S; Iglesias M; Cuatrecasas M; Ramón JM; García-Albéniz X; Grande L; Pera M
    Eur J Surg Oncol; 2016 Jan; 42(1):132-9. PubMed ID: 26385054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A competing risk analysis of colorectal cancer recurrence after curative surgery.
    Schellenberg AE; Moravan V; Christian F
    BMC Gastroenterol; 2022 Mar; 22(1):95. PubMed ID: 35241002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgeon's awareness of the synchronous liver metastases during colorectal cancer resection may affect outcome.
    Hamady ZZ; Malik HZ; Alwan N; Wyatt JI; Prasad KR; Toogood GJ; Lodge JP
    Eur J Surg Oncol; 2008 Feb; 34(2):180-4. PubMed ID: 17983724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.